GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioMedica PLC (FRA:OXOA) » Definitions » 3-Year EBITDA Growth Rate

Oxford BioMedica (FRA:OXOA) 3-Year EBITDA Growth Rate : 0.00% (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Oxford BioMedica 3-Year EBITDA Growth Rate?

Oxford BioMedica's EBITDA per Share for the six months ended in Jun. 2024 was €-0.22.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Oxford BioMedica was 40.80% per year. The lowest was -175.60% per year. And the median was 13.80% per year.


Competitive Comparison of Oxford BioMedica's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Oxford BioMedica's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioMedica's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioMedica's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Oxford BioMedica's 3-Year EBITDA Growth Rate falls into.



Oxford BioMedica 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Oxford BioMedica  (FRA:OXOA) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Oxford BioMedica 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Oxford BioMedica's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioMedica Business Description

Traded in Other Exchanges
Address
Windrush Court, Transport Way, Oxford, GBR, OX4 6LT
Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types.

Oxford BioMedica Headlines

No Headlines